These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
444 related articles for article (PubMed ID: 34150630)
1. Prognostic Implication of a Novel Metabolism-Related Gene Signature in Hepatocellular Carcinoma. Yuan C; Yuan M; Chen M; Ouyang J; Tan W; Dai F; Yang D; Liu S; Zheng Y; Zhou C; Cheng Y Front Oncol; 2021; 11():666199. PubMed ID: 34150630 [TBL] [Abstract][Full Text] [Related]
2. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma. Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X Front Oncol; 2023; 13():1182434. PubMed ID: 37346073 [TBL] [Abstract][Full Text] [Related]
3. An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma. Lin Z; Xu Q; Miao D; Yu F Front Oncol; 2021; 11():644416. PubMed ID: 33828988 [TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma. Li R; Zhao W; Liang R; Jin C; Xiong H Front Mol Biosci; 2022; 9():917839. PubMed ID: 35847972 [No Abstract] [Full Text] [Related]
5. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma. Liu GM; Zeng HD; Zhang CY; Xu JW Cancer Cell Int; 2019; 19():138. PubMed ID: 31139015 [TBL] [Abstract][Full Text] [Related]
6. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma. Li X; Lin J; Pan Y; Cui P; Xia J Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477 [No Abstract] [Full Text] [Related]
7. Bioinformatics analysis and experimental verification of the prognostic and biological significance mediated by fatty acid metabolism related genes for hepatocellular carcinoma. Zhu XR; Zhu JQ; Chen YF; Liu YY; Lu JJ; Sun J; Peng SQ; Chen MB; Du YP Front Oncol; 2022; 12():972744. PubMed ID: 35982956 [TBL] [Abstract][Full Text] [Related]
8. Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma. Chen C; Liu YQ; Qiu SX; Li Y; Yu NJ; Liu K; Zhong LM BMC Cancer; 2021 Jun; 21(1):693. PubMed ID: 34116652 [TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566 [TBL] [Abstract][Full Text] [Related]
10. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma. Chen S; Zhao E Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631 [TBL] [Abstract][Full Text] [Related]
11. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma. Li W; Lu J; Ma Z; Zhao J; Liu J Front Genet; 2019; 10():1323. PubMed ID: 32010188 [No Abstract] [Full Text] [Related]
12. Construction of a novel exosomes-related gene signature in hepatocellular carcinoma. Tao Q; Zhu K; Zhan Y; Zhang R; Lang Z; Yu Z; Wang M Front Cell Dev Biol; 2022; 10():997734. PubMed ID: 36105354 [No Abstract] [Full Text] [Related]
13. Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma. Chen Y; Huang M; Zhu J; Xu L; Cheng W; Lu X; Yan F Front Pharmacol; 2022; 13():857060. PubMed ID: 35496321 [No Abstract] [Full Text] [Related]
14. Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients. Huang S; Li D; Zhuang L; Zhang J; Wu J Front Med (Lausanne); 2022; 9():850343. PubMed ID: 35685422 [TBL] [Abstract][Full Text] [Related]
15. A novel tumor 4-driver gene signature for the prognosis of hepatocellular carcinoma. Guo H; Lu F; Lu R; Huang M; Li X; Yuan J; Wang F Heliyon; 2023 Jun; 9(6):e17054. PubMed ID: 37484410 [TBL] [Abstract][Full Text] [Related]
16. Stemness analysis in hepatocellular carcinoma identifies an extracellular matrix gene-related signature associated with prognosis and therapy response. Chen L; Zhang D; Zheng S; Li X; Gao P Front Genet; 2022; 13():959834. PubMed ID: 36110210 [No Abstract] [Full Text] [Related]
17. Development and validation of an eight-gene signature based predictive model to evaluate the prognosis of hepatocellular carcinoma patients: a bioinformatic study. Zhang J; Fu X; Zhang N; Wang W; Liu H; Jia Y; Nie Y Ann Transl Med; 2022 May; 10(9):524. PubMed ID: 35928748 [TBL] [Abstract][Full Text] [Related]
18. A novel five-gene metabolism-related risk signature for predicting prognosis and immune infiltration in endometrial cancer: A TCGA data mining. Huang H; Cai X; Lin J; Wu Q; Zhang K; Lin Y; Liu B; Lin J Comput Biol Med; 2023 Mar; 155():106632. PubMed ID: 36805217 [TBL] [Abstract][Full Text] [Related]
19. Identification and Validation of a Nine-Gene Amino Acid Metabolism-Related Risk Signature in HCC. Zhao Y; Zhang J; Wang S; Jiang Q; Xu K Front Cell Dev Biol; 2021; 9():731790. PubMed ID: 34557495 [No Abstract] [Full Text] [Related]
20. Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinoma. Zhu Z; Li L; Xu J; Ye W; Chen B; Zeng J; Huang Z PeerJ; 2020; 8():e9201. PubMed ID: 32518728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]